SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-017936
Filing Date
2024-05-06
Accepted
2024-05-06 16:59:24
Documents
20
Period of Report
2024-05-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51818
2 ex4-6.htm EX-4.6 122901
3 ex5-1.htm EX-5.1 55809
4 ex10-108.htm EX-10.108 246239
5 ex23-2.htm EX-23.2 4884
6 ex23-3.htm EX-23.3 4919
7 ex5-1_001.jpg GRAPHIC 6193
8 ex5-1_002.jpg GRAPHIC 2069
  Complete submission text file 0001493152-24-017936.txt   767110

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE jan-20240506.xsd EX-101.SCH 3006
10 XBRL LABEL FILE jan-20240506_lab.xml EX-101.LAB 34240
11 XBRL PRESENTATION FILE jan-20240506_pre.xml EX-101.PRE 22354
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3688
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 24918412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)